Oppenheimer Assumes Aerie Pharma (AERI) at Outperform

Oppenheimer analyst Francois Brisebois assumes coverage on Aerie Pharma (NASDAQ: AERI) with a Outperform rating and a price target of $24.00.

For an analyst ratings summary and ratings history on Aerie Pharma click here. For more ratings news on Aerie Pharma click here.

Shares of Aerie Pharma closed at $14.03 yesterday.

You May Also Be Interested In

• Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
• Berenberg Starts Interparfums SA (ITP:FP) at Buy
• Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'